ketoconazole has been researched along with bay n 7133 in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (96.67) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
| Durack, DT; Perfect, JR | 1 |
| Cauwenbergh, G | 1 |
| Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
| Meingassner, JG; Schaude, M | 1 |
| Beggs, WH; Hughes, CE | 2 |
| Meunier, F | 1 |
| Hoeprich, PD; Merry, JM | 2 |
| Gugnani, HC; Okeke, CN | 1 |
| Brummer, E; Hoyos, GL; Lefler, E; McEwen, JG; Restrepo, A; Stevens, DA | 1 |
| Lefler, E; Stevens, DA | 1 |
| Brummer, E; Lefler, E; Perlman, AM; Stevens, DA | 1 |
| Durack, DT; Smego, RA | 1 |
| Espinel-Ingroff, A; Gebhart, RJ; Shadomy, S | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
| Hiratani, T; Plempel, M; Yamaguchi, H | 1 |
| Drutz, DJ; Graybill, JR; Kaster, SR | 2 |
| Fromtling, RA; Shadomy, S; Yu, HP | 2 |
| Muller, G; Sobel, JD | 1 |
| Nusch, W; Plempel, M | 1 |
| Plempel, M | 2 |
| Levine, HB | 1 |
| Espinel-Ingroff, A; Kerkering, TM; Shadomy, S | 1 |
| Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR | 1 |
| Hiratani, T; Yamaguchi, H | 1 |
30 other study(ies) available for ketoconazole and bay n 7133
| Article | Year |
|---|---|
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Meningitis, Haemophilus; Rabbits; Triazoles | 1985 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
A diffusion chamber technique for testing of antifungal drugs against Sporothrix schenckii in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Mice; Potassium Iodide; Sporothrix; Sporotrichosis; Triazoles | 1986 |
Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Ketoconazole; Miconazole; Triazoles | 1987 |
Irrelevance of growth phase with respect to the Bay n 7133 and ICI 153,066 susceptibilities of Candida albicans.
Topics: Anti-Bacterial Agents; Candida albicans; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles | 1986 |
Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents.
Topics: Aspergillus fumigatus; Candida; Candida albicans; Chromatography, High Pressure Liquid; Cryptococcus neoformans; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Ketoconazole; Mucorales; Mycoses; Rifampin; Triazoles | 1986 |
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
Topics: Antifungal Agents; Candida; Candida albicans; Cryptococcus; Cryptococcus neoformans; Culture Media; Humans; Ketoconazole; Microbial Sensitivity Tests; Triazoles | 1986 |
In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.
Topics: Animals; Antifungal Agents; Culture Media; Econazole; Fungi; Imidazoles; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests; Morpholines; Thiabendazole; Triazoles | 1987 |
Study of current and new drugs in a murine model of acute paracoccidioidomycosis.
Topics: Amphotericin B; Animals; Imidazoles; Ketoconazole; Lung; Male; Mice; Mice, Inbred BALB C; Paracoccidioides; Paracoccidioidomycosis; Spleen; Triazoles | 1985 |
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Imidazoles; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |
Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Imidazoles; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Time Factors; Triazoles | 1985 |
Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Imidazoles; Ketoconazole; Mice; Triazoles | 1985 |
In vitro susceptibility testing of Naegleria fowleri to ketoconazole, BAYn7133, and allopurinol riboside.
Topics: Allopurinol; Amoeba; Amphotericin B; Animals; Antiprotozoal Agents; Ketoconazole; Microbial Sensitivity Tests; Ribonucleosides; Triazoles | 1984 |
In vitro studies with R 51,211 (itraconazole).
Topics: Antifungal Agents; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Morpholines; Triazoles | 1984 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
In-vitro studies of a new oral azole antimycotic, BAY N 7133.
Topics: Antifungal Agents; Culture Media; Drug Resistance, Microbial; Fungi; Hydrogen-Ion Concentration; Imidazoles; Ketoconazole; Microbial Sensitivity Tests; Piperazines; Triazoles | 1983 |
Treatment of experimental murine aspergillosis with BAY n7133.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Ketoconazole; Lung; Male; Mice; Mice, Inbred BALB C; Triazoles | 1983 |
In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139.
Topics: Antifungal Agents; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Fungi; Imidazoles; Ketoconazole; Miconazole; Species Specificity; Triazoles | 1983 |
Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Imidazoles; Ketoconazole; Rats; Rats, Inbred Strains; Triazoles | 1983 |
Comparative activities of Bay n7133, ICI 153,066, and ketoconazole in murine cryptococcosis.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Triazoles | 1983 |
[Microbiological determination of the oral antifungal agent Bay N 7133 and ketoconazole in cervical and vaginal secretion of patients].
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Assay; Candida; Candidiasis, Vulvovaginal; Cervix Mucus; Female; Humans; Ketoconazole; Leukorrhea; Triazoles | 1983 |
[Correlation of in vitro and in vivo actions of azole antimycotics].
Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles | 1984 |
A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Coccidioides; Coccidioidomycosis; Drug Evaluation, Preclinical; Female; Imidazoles; Ketoconazole; Mice; Spores, Fungal; Triazoles | 1984 |
In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
Topics: Antifungal Agents; Arthrodermataceae; Blastomyces; Candida; Coccidioides; Cryptococcus neoformans; Drug Evaluation, Preclinical; Histoplasma; Imidazoles; Ketoconazole; Miconazole; Morpholines; Sporothrix; Triazoles | 1984 |
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
Topics: Antifungal Agents; Candida; Candida albicans; Cryptococcus; Cryptococcus neoformans; Culture Media; Echinocandins; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Triazoles | 1984 |
[Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
Topics: Antifungal Agents; Candida albicans; Depression, Chemical; Drug Resistance, Microbial; Ergosterol; Ketoconazole; Morpholines; Naphthalenes; Terbinafine; Triazoles | 1994 |